Dr Gene Anthony Falkowski Jr, DO in Anchorage, AK - Medicare Orthopedic Surgery

Dr Gene Anthony Falkowski Jr, DO is a medicare enrolled "Orthopaedic Surgery" physician in Anchorage, Alaska. He went to Philadelphia College Of Osteopathic Medicine and graduated in 2012 and has 12 years of diverse experience with area of expertise as Orthopedic Surgery. He is a member of the group practice Orthoalaska Llc and his current practice location is 3831 Piper St Ste S220, Anchorage, Alaska. You can reach out to his office (for appointments etc.) via phone at (907) 261-8252.

Dr Gene Anthony Falkowski Jr is licensed to practice in Pennsylvania (license number OT014516) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1841554201.

Contact Information

	Dr Gene Anthony Falkowski Jr, DO
	3831 Piper St Ste S220, Anchorage, AK 99508
	(907) 261-8252
	(907) 261-8220

Physician's Profile

Full Name	Dr Gene Anthony Falkowski Jr
Gender	Male
Speciality	Orthopedic Surgery
Experience	12 Years
Location	3831 Piper St Ste S220, Anchorage, Alaska
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Gene Anthony Falkowski Jr attended and graduated from Philadelphia College Of Osteopathic Medicine in 2012

NPI Data:

NPI Number: 1841554201
Provider Enumeration Date: 07/01/2012
Last Update Date: 03/21/2019

Medicare PECOS Information:

PECOS PAC ID: 2567694052
Enrollment ID: I20180921001047

Medical Identifiers

Medical identifiers for Dr Gene Anthony Falkowski Jr such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1841554201	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207X00000X	Orthopaedic Surgery	OT014516 (Pennsylvania)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Mat-su Regional Medical Center	Palmer, AK	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Orthoalaska Llc	2961705520	125

News Archive

Xcellerex and Itero collaborate in production of an undisclosed therapeutic protein

Xcellerex, Inc. and Itero Biopharmaceuticals, Inc. announced today that they have signed a Letter of Intent to enter into a strategic collaboration for the production of Itero's lead product, an undisclosed commercially differentiated therapeutic protein. Itero will initiate technology transfer for the product to Xcellerex immediately.

Study suggests that inhibiting FOXO1 protein could speed diabetic wound healing

A protein that normally fosters tissue repair instead acts to inhibit healing when sugar levels are high, according to a study in The Journal of Cell Biology. The role reversal helps explain why wounds heal slowly in people with diabetes.

Fluence Analytics announces distribution agreement with Nihon Rufuto in Japan

Fluence Analytics, a manufacturer of industrial and laboratory analytics products, today announced it has signed a distribution agreement with Nihon Rufuto, a Japanese company specializing in the import and domestic sales of scientific instruments.

New findings identify mGlu2/3 receptors as a promising treatment target for cocaine addicts

Glutamate is the primary excitatory neurotransmitter in the brain, which has been implicated in drug addiction. Metabotropic glutamate receptors (mGluRs) represent a family of G-protein coupled receptors that modulate glutamate transmission. Glutamate is an important neurotransmitter involved in learning and memory. Today, these receptors are considered to be promising targets for drug discovery, with therapeutic potential to treat various neurological and psychiatric disorders, including drug addiction.

Enrollment complete in Jennerex' Phase 1 trial of JX-594 IV administration for solid tumors

Jennerex, Inc., a clinical-stage cancer biotherapeutics company, today announced that it has completed patient enrollment in a Phase 1 clinical trial evaluating the intravenous (IV) administration of JX-594, the company's lead product for the treatment of solid tumors. Jennerex expects to report the results from this trial at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting in May 2010.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Gene Anthony Falkowski Jr allows following entities to bill medicare on his behalf.

Entity Name	Orthoalaska Llc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1336504521 PECOS PAC ID: 2961705520 Enrollment ID: O20160114002729

News Archive

Xcellerex and Itero collaborate in production of an undisclosed therapeutic protein

Study suggests that inhibiting FOXO1 protein could speed diabetic wound healing

Fluence Analytics announces distribution agreement with Nihon Rufuto in Japan

New findings identify mGlu2/3 receptors as a promising treatment target for cocaine addicts

Enrollment complete in Jennerex' Phase 1 trial of JX-594 IV administration for solid tumors

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Gene Anthony Falkowski Jr is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Gene Anthony Falkowski Jr, DO 3831 Piper St Ste S220, Anchorage, AK 99508-4680 Ph: (907) 563-3145	Dr Gene Anthony Falkowski Jr, DO 3831 Piper St Ste S220, Anchorage, AK 99508 Ph: (907) 261-8252

News Archive

Xcellerex and Itero collaborate in production of an undisclosed therapeutic protein

Study suggests that inhibiting FOXO1 protein could speed diabetic wound healing

Fluence Analytics announces distribution agreement with Nihon Rufuto in Japan

New findings identify mGlu2/3 receptors as a promising treatment target for cocaine addicts

Enrollment complete in Jennerex' Phase 1 trial of JX-594 IV administration for solid tumors

Orthopaedic Surgery Doctors in Anchorage, AK

Loren J Jensen, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 4100 Lake Otis Pkwy, Suite 314, Anchorage, AK 99508 Phone: 907-274-2425 Fax: 907-274-2428
Dr. Adrian B Ryan, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3831 Piper St, Suite S-220, Anchorage, AK 99508 Phone: 907-563-3145 Fax: 907-561-3967
Dann J Laudermilch, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3801 Lake Otis Pkwy Ste 300, Anchorage, AK 99508 Phone: 907-562-2277 Fax: 907-563-3460
Dr. Ross Nathan Brudenell, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3801 Lake Otis Pkwy, Ste 300, Anchorage, AK 99508 Phone: 907-562-2277 Fax: 907-563-3460
Rabun Samuel Fox, Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3831 Piper St Ste 220, Anchorage, AK 99508 Phone: 907-563-3145 Fax: 907-561-3967
Dr. Andrew Garret Shacklett, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 5955 Zeamer Ave, Anchorage, AK 99506 Phone: 907-580-1571
Erik Woelber, Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 4015 Lake Otis Pkwy Ste 201, Anchorage, AK 99508 Phone: 907-771-3500 Fax: 907-771-3550

Dr Gene Anthony Falkowski Jr, DO - Medicare Orthopedic Surgery in Anchorage, AK

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

Xcellerex and Itero collaborate in production of an undisclosed therapeutic protein

Study suggests that inhibiting FOXO1 protein could speed diabetic wound healing

Fluence Analytics announces distribution agreement with Nihon Rufuto in Japan

New findings identify mGlu2/3 receptors as a promising treatment target for cocaine addicts

Enrollment complete in Jennerex' Phase 1 trial of JX-594 IV administration for solid tumors

Medicare Reassignments

Xcellerex and Itero collaborate in production of an undisclosed therapeutic protein

Study suggests that inhibiting FOXO1 protein could speed diabetic wound healing

Fluence Analytics announces distribution agreement with Nihon Rufuto in Japan

New findings identify mGlu2/3 receptors as a promising treatment target for cocaine addicts

Enrollment complete in Jennerex' Phase 1 trial of JX-594 IV administration for solid tumors

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Xcellerex and Itero collaborate in production of an undisclosed therapeutic protein

Study suggests that inhibiting FOXO1 protein could speed diabetic wound healing

Fluence Analytics announces distribution agreement with Nihon Rufuto in Japan

New findings identify mGlu2/3 receptors as a promising treatment target for cocaine addicts

Enrollment complete in Jennerex' Phase 1 trial of JX-594 IV administration for solid tumors

Orthopaedic Surgery Doctors in Anchorage, AK